Degenerative Lumbar Spinal Stenosis Clinical Trial
Official title:
Traditional Chinese Medical Comprehensive Conservative Treatment for the Degenerative Lumbar Spinal Stenosis
Lumbar degenerative disease is a common disease develops into degenerative lumbar spinal stenosis(DLSS)in the elderly and eventually. The long course of disease and other characteristics determine that conservative treatment cannot be effective in a short time, surgery is recommended to relieve symptoms quickly. However, the incidence of complications and disease recurrence rate after surgical treatment is high, and the reoperation rate is as high as 30-50%. Conservative treatment has the advantages of low price and high acceptance, so the treatment strategy first returns to conservative treatment.The complexity and repeatability of DLSS are the main reasons for the adoption of comprehensive treatment in modern medicine, but the efficacy is not significant. Traditional Chinese medicine (TCM) has its own theories and various methods to treat low back pain.
Status | Recruiting |
Enrollment | 94 |
Est. completion date | September 30, 2024 |
Est. primary completion date | June 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 85 Years |
Eligibility | Inclusion Criteria: - Diagnostic of Degenerative Lumbar Spinal Stenosis. - Males and females aged between 40 and 85. - Low back pain and leg pain accompanied by typical neurogenic intermittent claudication symptoms, lasting ?3 months. - The effect of 3 months conservative treatment(Oral painkillers + any 1 physical therapy) was not ideal(Less than 50% relief from pain or functional limitations). - Having any of the following surgical indications: 1.Low back and leg pain after exercise, affecting life and work (the patient felt seriously affecting life and work);2. Progressive claudication(Continuous walking distance is less than 100m),or standing time is decreasing(Standing time at a time reduced to 50% of the onset);3. Those with obvious neurological defects(Suddenly appear the paresthesia of the distribution area of spinal nerve, such as numbness, acid bilges, acupuncture feeling, limb hair cool). - The patient refused surgical treatment. - Willing to participate in this study, and signed the informed consent. Exclusion Criteria: - Patients with vasogenic intermittent claudication. - Patients with other bone and joint diseases, including spinal vertebra fracture, lumbar tuberculosis, spinal tumor and other lesions, or rheumatism, rheumatoid arthritis. - Patients with hematopoietic system(anemia,aplastic anemia), cardiocerebral vascular system(History of cerebral hemorrhage, Serious cardiovascular disease), endocrine system(Poor glycemic control in diabetes, such as postprandial blood glucose over 12mmol/L) and other serious primary diseases, tumors and psychosis. - Patients with scoliosis >15° or disc instability (rotation >10° or translation >4mm). - Patients after minimally invasive surgery and open surgery. - Patients who received an epidural steroid injection within 6 months. - The patient is allergic to Traditional Chinese medicine, history of skin allergy and allergic constitution. - The treatment site has subcutaneous unknown lump, the skin is red and swollen broken ulceration inflammation or skin lesions, etc. - Patients with severe cauda equina syndrome. - Women who are menstruating, pregnant or breastfeeding. - Patients with strong preferences for treatment, disobedience to random assignment, and poor compliance. |
Country | Name | City | State |
---|---|---|---|
China | Dongzhimen hospital affiliated to Bejing University of Chinese Medicine | Beijing | Beijing |
Lead Sponsor | Collaborator |
---|---|
Beijing University of Chinese Medicine |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The short-term response rate | The NASS guidelines recommend the use of response rate as the primary criterion for determining performance due to the variety, complexity and repeatability of DLSS performance. The Zurich Claudication Questionnaire (ZCQ) is considered by the North American Spine Association (NASS) to be the best and most specific assessment method. It is the "gold standard" to evaluate the function of patients with lumbar spinal stenosis. Therefore, as the standard for calculating effective rate in this study, the decrease of symptom severity subscale and physiological function subscale score =0.5 points represents "success". A decrease of =2.5 points in the satisfaction subscale represents "success". When at least two subscales are judged to be "successful", the treatment is judged to be effective, thus the response rate is calculated.In ZCQ, the greater the difference between the two measurements before and after (the lower the score of the latter measurement), the better degree of recovery. | The 3rd month | |
Primary | The long-term response rate | Using the Zurich Claudication Questionnaire (ZCQ) as the standard for calculating response rate in this study, the decrease of symptom severity subscale and physiological function subscale score =0.5 points represents "success". A decrease of =2.5 points in the satisfaction subscale represents "success". When at least two subscales are judged to be "successful", the treatment is judged to be effective, thus the response rate is calculated.In ZCQ, the greater the difference between the two measurements before and after (the lower the score of the latter measurement), the better degree of recovery. | The 15rd month | |
Secondary | Changes in pain level | The severity of leg pain and low back pain within 24 hours was assessed by the Digital Pain Scale (NRS).10 is the highest score, indicating unbearable pain. 0 is the lowest score, meaning no pain.The higher the NRS score, the more intense of the pain. | The time points of evaluation were baseline, 3,6,9,12 and 15 months. | |
Secondary | Changes in general health status | Chinese version of SF12 was used to evaluate the overall health status, including total physical health score and total mental health score.After the formula score calculation, the higher the score, the better the health. | The time points of evaluation were baseline, 3,6,9,12 and 15 months. | |
Secondary | Changes in locomotor function | The Oswestry Disability Index (ODI) consists of 10 items, including pain, individual disability and general disability. The lowest score for each item is 0, and the highest score is 5, with higher scores indicating higher levels of dysfunction. After the corresponding scores of the answers of the 10 items are accumulated, the percentage of the answers to the highest total score (50 points) is calculated, which is ODI. The higher the score is, the more serious the patient's dysfunction is. | The time points of evaluation were baseline, 3,6,9,12 and 15 months. | |
Secondary | Incidence of surgery | The incidence of patients attending surgical treatment was recorded at any time. | The evaluation time point was 3,6,9,12, and 15 months. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02592642 -
the Evaluation of Four Non-operative Treatments for Degenerative Lumbar Spinal Stenosis
|
N/A | |
Recruiting |
NCT04469387 -
Preventive Effect of Limited Decompression on Adjacent Segment Following Posterior Lumbar Interbody Fusion
|
N/A | |
Completed |
NCT03302520 -
Comparison of Bioactive Glass Ceramics Spacer and PEEK Cages in Posterior Lumbar Interbody Fusion: A Prospective, RCT
|
N/A | |
Completed |
NCT03532945 -
A Follow-up Study to Evaluate the Efficacy and Safety of Novomax in Posterior Lumbar Interbody Fusion
|
N/A | |
Completed |
NCT03560401 -
Is Postoperative Bracing Necessary After Spine Surgery for Degenerative Conditions
|
N/A | |
Recruiting |
NCT06335511 -
Decompression Versus Instrumented Fusion for Lumbar Degenerative Disease. Clinical and Biomechanical Outcome Study
|
||
Not yet recruiting |
NCT06106061 -
Effectiveness and Safety of the Facet Fixation (FFX®) Implant in the Treatment of Degenerative Lumbar Spinal Stenosis
|
N/A | |
Completed |
NCT03302507 -
Biportal Endoscopy Spine Surgery (BESS )Versus Unilateral Laminotomy Bilateral Decompression (ULBD ): RCT, Non-inferiority Trial
|
N/A | |
Completed |
NCT02644746 -
Efficacy and Safety of Acupuncture for Degenerative Lumbar Spinal Stenosis
|
N/A | |
Completed |
NCT04406987 -
Instability in the Lumbar Spine of Patients With Age Related Changes and Narrowing of the Spinal Canal (Spinal Stenosis)
|
||
Recruiting |
NCT04407338 -
Efficacy and Tolerance Study of B-DYN Versus Conventional Fusion in the Treatment of Lumbar Stenosis on the Degree of Post-operative Functional Incapacity (BDYNCLIN)
|
N/A | |
Recruiting |
NCT03553186 -
Tranexamic Acid in Adult Spinal Deformity Surgery
|
Phase 3 | |
Recruiting |
NCT05645497 -
Evaluation of the Efficacy and Safety of the FACET FIXation Implant.
|
||
Enrolling by invitation |
NCT04086784 -
3D-printed Porous Titanium Alloy Cages Versus PEEK Cages in Patients With Osteoporosis
|
||
Recruiting |
NCT05375201 -
Clinical Decision-Making and Virtual Reality Exercise
|
N/A | |
Completed |
NCT05203666 -
Clinical and Radiological Outcomes Following Insertion of a Novel Removable Percutaneous Interspinous Process Spacer: an Initial Experience.
|
||
Recruiting |
NCT04467944 -
Effect of Pre-existing Adjacent Segment Degeneration on Long-term Effectiveness After Lumbar Fusion Surgery
|
||
Active, not recruiting |
NCT03562936 -
The NORDSTEN Studies/The Observational Cohort Study
|
||
Terminated |
NCT00627497 -
DIAM™ Spinal Stabilization System vs. Decompression, Formerly vs. Posterolateral Fusion
|
Phase 3 | |
Completed |
NCT02121249 -
Clinical Trial of Minimally Invasive Robotic Spine Surgery
|
N/A |